![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/357 | (2006.01) |
A61K 31/366 | (2006.01) | ||
A61P 3/10 | (2006.01) | ||
A61P 5/48 | (2006.01) | ||
C12N 5/071 | (2010.01) |
(11) | Number of the document | 3129019 |
(13) | Kind of document | T |
(96) | European patent application number | 15717842.7 |
Date of filing the European patent application | 2015-04-09 | |
(97) | Date of publication of the European application | 2017-02-15 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
(46) | Date of publication of the claims translation | 2019-11-11 |
(86) | Number | PCT/EP2015/057755 |
Date | 2015-04-09 |
(87) | Number | WO 2015/155303 |
Date | 2015-10-15 |
(30) | Number | Date | Country code |
14164471 | 2014-04-11 | EP |
(72) |
LI, Jin, AT
KUBICEK, Stefan, AT
|
(73) |
CeMM - Forschungszentrum für Molekulare Medizin GmbH,
Lazarettgasse 14 / AKH BT 25.3, 1090 Wien,
AT
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Artemizinino junginių ir gefirino agonistų medicininis panaudojimas |
MEDICAL USE OF ARTEMISININ COMPOUNDS AND GEPHYRIN AGONISTS |
Payment date | Validity (years) | Amount | |
2020-04-02 | 6 | 139.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-04-09 |